Login / Signup
Li Du
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 2
Top Topics
Venous Thromboembolism
Clinical Trial
Phase Iii
Atrial Fibrillation
Top Venues
Liver international : official journal of the International Association for the Study of the Liver
Hepatology (Baltimore, Md.)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hongyu Xiang
,
Chang Liu
,
Zhuanglong Xiao
,
Li Du
,
Ning Wei
,
Fang Liu
,
Yuhu Song
Enoxaparin attenuates pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome by inhibiting oncostatin M expression.
Liver international : official journal of the International Association for the Study of the Liver
(2022)
Jacey J Liu
,
Bing Xin
,
Li Du
,
Lydia Chen
,
Yanyan Long
,
Gen-Sheng Feng
Pharmaceutical SH2 domain-containing protein tyrosine phosphatase 2 inhibition suppresses primary and metastasized liver tumors by provoking hepatic innate immunity.
Hepatology (Baltimore, Md.)
(2022)